The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Mitogen-Activated Protein Kinases and Retinal Ischemia
Abstract
purpose. Mitogen-activated protein kinases (MAPKs), consisting of three major enzymes—extracellular signal-regulated kinase (ERK), p38, and c-jun N-terminal kinase (JNK)—couple cell-surface receptors to critical regulatory targets and gene transcription. We hypothesized that MAPKs are differentially expressed and have distinct functions after retinal ischemia. methods. Rats were subjected to retinal ischemia by elevation of intraocular pressure. Changes in MAPK expression were examined by Western blot of whole retinal homogenates and by immunohistochemistry of retinal cryosections. Phosphorylated (activated) ERK, p38, and JNK proteins were localized by fluorescent double labeling. The functional significance of activated MAPKs was assessed using pharmacological antagonists. Specific MAPK blockade was documented by kinase assay and immunohistochemistry for phosphorylated target proteins. The outcome after ischemia was examined with electroretinography (ERG), by measuring retinal cell layer thickness in paraffin-embedded sections, and by TUNEL staining on retinal cryosections. Data were analyzed using ANOVA and post hoc t-test, with P < 0.05 considered significant. results. Expression of phosphorylated JNK and p38 increased significantly after ischemia and followed a specific time course, beginning at 1 hour, and persisting up to 1 week later. JNK and p38 were expressed in the nuclei of ganglion and amacrine cells, the outer plexiform layer, the nerve fiber layer, and the axonal terminals of bipolar cells. Phosphorylated ERK was expressed in Müller cells, peaking at 1 to 6 hours after ischemia. Blocking activation of p38 or ERK significantly improved recovery of the ERG b-wave after ischemia, dramatically decreased thinning of the inner nuclear layers, and decreased the percentage of TUNEL-positive cells. conclusions. The MAPKs each demonstrate a specific cellular distribution after ischemia, and ERK and p38 are linked to apoptosis. Blockade of p38 or ERK provides significant protection from ischemic damage, suggesting a novel therapeutic role for MAPK inhibition in neuroprotection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“JNK and p38 phosphorylation is increased after retinal ischemia, mainly in amacrine, ganglion and bipolar cells while ERK is activated in MG cells [ 25 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [25]
In the citing paper
“Multiple MEK pathways have been also reported to be involved in retinal ischemia, with each demonstrating a specific pattern of cellular expression, while the blockade of p38 or ERK can provide significant protection from ischemic damage [ 25 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [25]
In the citing paper
“Specific blockage of ERK and p38 phosphorylation, but not of JNK, prevents ischemia-induced apoptosis and improves retinal function in a rat model [ 25 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [25]
In the citing paper
“Although inhibition of p38 or ERK has been shown to confer significant protection from ischemic damage as assessed by retinal cell layer thickness and apoptosis measurement [ 25 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [25]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · cited 2×
“TdT-mediated dUTP-biotin nick-end labeling (TUNEL) staining was performed on 10- m frozen retinal sections with a TdT-fluorescein fragmentation detection kit (FragEL DNA; Oncogene, La Jolla, CA), with procedures modified from Gavrieli et al.(28) and as we described previously.”
MethodMammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111 · cited 2×
“03-0451 Mitogen-activated protein kinases (MAPKs) couple cell-surface receptors to critical regulatory targets and gene transcription within cells, are responsive to chemical and physical stresses, and play a key role in cell survival and adaptation.(1) MAPKs are activated by G-protein–linked receptors.”
BackgroundAlessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393 · cited 2×
“It has approximately 100-fold greater affinity for MEK than the other commonly used MEK inhibitor, PD098059.(32,33) U0126 (26 mM in 1% DMSO) was injected intraperitoneally (2000 g/kg), 1 hour before ischemia.”
MethodSP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 4×
“SP600125 is a cell-permeable, reversible, and highly specific inhibitor of JNK.(37) We prepared SP600125 as a 100-mM stock solution in DMSO and injected 2 L of a 1-mM solution (1% DMSO) before and after ischemia, resulting in an estimated vitreous concentration of 63 M after each injection.”
MethodInfluentialSweatt, J. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00054.x · Cited by 1,131
Serine/Threonine Protein Kinases and Apoptosis
Cross, T. G., Scheel-Toellner, D., Henriquez, N. V., Deacon, E., Salmon, M., & Lord, J. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4836 · Cited by 690 · cited 1×
“The MAPKs, modulators of transcription, affect the rate of apoptosis through mechanisms that probably modify gene expression.(5) However, it has not been determined whether MAPKs have a functional role in retinal ischemia or in the induction of apoptosis after ischemia.”
BackgroundCell-Permeable Peptide Inhibitors of JNK
Bonny, C., Oberson, A., Negri, S., Sauser, C., & Schorderet, D. F. (2001) · Diabetes · doi:10.2337/diabetes.50.1.77 · Cited by 571
Activation of Trk neurotrophin receptors in the absence of neurotrophins
Lee, F. S., & Chao, M. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061020198 · Cited by 482 · cited 1×
“MAPKs are activated by G-protein–linked receptors.(2,3) Their expression is influenced by protein kinases A and C, receptor tyrosine kinases, cytokines, and other stress molecules.”
BackgroundIschemic Preconditioning: From Adenosine Receptor to KATP Channel
Cohen, M. V., Baines, C. P., & Downey, J. M. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.79 · Cited by 475 · cited 1×
“Moreover, under some circumstances, such as in the myocardium, p38 and JNK may actually play an apparently paradoxical, but protective, role by stimulating ischemic preconditioning protection.(12,13) ERK, JNK, and p38 expression increased after focal and global cerebral ischemia in rats and gerbils, each demonstrating…”
BackgroundMEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia
Alessandrini, A., Namura, S., Moskowitz, M. A., & Bonventre, J. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12866 · Cited by 464 · cited 2×
“When phosphorylated, the vesicles dissociate and release neurotransmitters.(17) Excessive release of glutamate and aspartate leads to neuronal damage after ischemia.”
BackgroundResult
Cited by
Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion
Mathew, B., Ravindran, S., Liu, X., Torres, L., Chennakesavalu, M., Huang, C.-C., Feng, L., Zelka, R., Lopez, J., Sharma, M., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.016 · Cited by 313
Self-citationThe RAGE Axis in Early Diabetic Retinopathy
Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Ho¨rig, H., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1409 · Cited by 200
King, R. E., Kent, K. D., & Bomser, J. A. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.11.003 · Cited by 192
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
Caprara, C., & Grimm, C. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.003 · Cited by 176
Effects of p38 MAPK Inhibition on Early Stages of Diabetic Retinopathy and Sensory Nerve Function
Du, Y., Tang, J., Li, G., Berti-Mattera, L., Lee, C. A., Bartkowski, D., Gale, D., Monahan, J., Niesman, M. R., Alton, G., et al. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3674 · Cited by 136
“Suppression of p38 MAPK has been found to inhibit acute lung inflammation,(8,9) ischemia/ reperfusion,(10) rheumatoid arthritis, Alzheimer’s disease, and inflammatory bowel disease, as well as in ocular ischemia– reperfusion injury.(14) The demonstrated role of p38 MAPK in the development of inflammation in a variety…”
BackgroundJNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death
Fernandes, K. A., Harder, J. M., Fornarola, L. B., Freeman, R. S., Clark, A. F., Pang, I., John, S. W. M., & Libby, R. T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.02.003 · Cited by 143
Zheng, Y., Liu, Y., Ge, J., Wang, X., Liu, L., Bu, Z., & Liu, P. (2010) · PubMed Central · Cited by 157
Activation of Autophagy in a Rat Model of Retinal Ischemia following High Intraocular Pressure
Piras, A., Gianetto, D., Conte, D., Bosone, A., & Vercelli, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022514 · Cited by 133
“6 cm above the animal’s eye [72], [73].”
BackgroundDiabetic Retinopathy, Superoxide Damage and Antioxidants
dos Santos, J. M., Mohammad, G., Zhong, Q. P. W., & Kowluru, R. A. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794480507 · Cited by 115
“Hyperglycemia has been shown to markedly stimulate the activation of ERK 1/2, c-Jun NH2-terminal kinase, stress activated protein kinase and p38MAPK in retinal cells [104].”
BackgroundCrocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice
Ishizuka, F., Shimazawa, M., Umigai, N., Ogishima, H., Nakamura, S., Tsuruma, K., & Hara, H. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.02.007 · Cited by 111
“Antioxidants prevent activation of MAPK and redox-sensitive transcriptional factors (Wen et al., 2006; Yagi et al., 2009), and members of each major MAPK subfamily (JNK, p38, and ERK 1/2) have been implicated in the neuronal injury induced by retinal ischemia (Roth et al., 2003).”
BackgroundFischer, A. J., Scott, M. A., & Tuten, W. (2009) · Glia · doi:10.1002/glia.20743 · Cited by 105
“addition, these findings are consistent with a report demonstrating MAPK-signaling in M€ uller glia in the rat retina following an ischemic insult (Roth et al., 2003).”
ResultZhang, S., Wang, H., Lu, Q., Qing, G., Wang, N., Wang, Y., Li, S., Yang, D., & Yan, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.029 · Cited by 104
Fischer, A. J., Zelinka, C. P., Gallina, D., Scott, M. A., & Todd, L. J. (2014) · Glia · doi:10.1002/glia.22703 · Cited by 111
“Activation of p38 MAPK in retinal glia is most often associated with ocular inflammation, ischemic stress or infection (Roth et al., 2003; Shamsuddin and Kumar, 2011; Takeda et al., 2002).”
BackgroundAxon injury signaling and compartmentalized injury response in glaucoma
Syc‐Mazurek, S. B., & Libby, R. T. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.002 · Cited by 99
“axonal injury and ocular hypertension) and pJNK is present in RGCs in human glaucoma patients (Fernandes et al., 2012; Isenmann and Bahr, 1997; Kwong and Caprioli, 2006; Levkovitch-Verbin et al., 2005; Lukas et al., 2009; Munemasa et al., 2006; Pelzel et al., 2010; Roth et al., 2003; Tezel et al., 2003).”
BackgroundNeuroprotection from Retinal Ischemia/Reperfusion Injury by NOX2 NADPH Oxidase Deletion
Yokota, H., Narayanan, S. P., Zhang, W., Liu, H., Rojas, M., Xu, Z., Lemtalsi, T., Nagaoka, T., Yoshida, A., Brooks, S. E., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8318 · Cited by 92
“Activation of MAPKs, such as ERK, p38, and JNK has been reported during retinal I/R.(37) MAPKs are redox sensitive, and inhibition of ERK and p38 has been shown to limit neurode-”
BackgroundMethodInfluentialRetinal ganglion cell apoptotic pathway in glaucoma
Levkovitch-Verbin, H. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.05.005 · Cited by 97
Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
Syc-Mazurek, S. B., Fernandes, K. A., Wilson, M. P., Shrager, P., & Libby, R. T. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0214-8 · Cited by 74
Fang, I., Yang, C., & Yang, C.-H. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.12.001 · Cited by 76
“Several experimental studies have shown significantly increased the phospho-p38, phospho-JNK, and phospho-ERK levels after retinal ischemia, and the blockade of these MAPKs provides significant protection from ischemic damages (Ishizuka et al., 2013; Roth et al., 2003).”
BackgroundFu, Q., Hu, B., Wu, W., Pepinsky, R. B., Mi, S., & So, K. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1199 · Cited by 72
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Multiple MEK pathways have been also reported to be involved in retinal ischemia, with each demonstrating a specific pattern of cellular expression, while the blockade of p38 or ERK can provide significant protection from ischemic damage [25].”
BackgroundInfluentialMitochondrial Potassium ATP Channels and Retinal Ischemic Preconditioning
Roth, S., Dreixler, J. C., Shaikh, A. R., Lee, K. H., & Bindokas, V. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1068 · Cited by 63
“For ischemia, the IOP was increased to 110 mm Hg by elevating the saline reservoir above the eye for 45 minutes.(17,18) The degree of IOP elevation differed for IPC and ischemia because in our previous studies,(18) we found that IPC protection was more consistently produced using a higher pressure for the required bri…”
MethodResultInfluentialSelf-citationNovel role for the δ‐opioid receptor in hypoxic preconditioning in rat retinas
Peng, P., Huang, H., Lee, Y., Chen, Y., & Ma, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05807.x · Cited by 62
“However, other studies have shown that the activation of ERK is harmful to RGCs or stressed retinas (Roth et al. 2003; Luo et al. 2007).”
Biermann, J., Lagrèze, W. A., Dimitriu, C., Stoykow, C., & Goebel, U. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4894 · Cited by 63
Regulation of cell death and survival pathways in experimental glaucoma
Levkovitch-Verbin, H., Harizman, N., Dardik, R., Nisgav, Y., Vander, S., & Melamed, S. T. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.04.011 · Cited by 59
Kim, B.-J., Silverman, S. M., Liu, Y., Wordinger, R. J., Pang, I., & Clark, A. F. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0093-4 · Cited by 58
“Our findings of neuroprotection are in disagreement with those previously published by Roth and colleagues, who reported a lack of protection by two different JNK inhibitors including SP600125 [57].”
BackgroundResultRole of NF-κB and MAPKs in Light-Induced Photoreceptor Apoptosis
Yang, L.-P., Zhu, X. A., & Tso, M. O. M. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0871 · Cited by 59
Mester, L., Szabó, A., Atlasz, T., Szabadfi, K., Reglődi, D., Kiss, P., Rácz, B., Tamás, A., Gallyas, F., Sümegi, B., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9049-6 · Cited by 58
“\ 0.05 versus BCCAO ? saline-treated retinas Elevated activation of ERK generally induces cytoprotection, although contradictory data also exist showing proapoptotic effects of the kinase pathway or no contribution to cell death (Roth et al. 2003; Munemasa et al. 2005).”
BackgroundMethodInfluentialJUN is important for ocular hypertension-induced retinal ganglion cell degeneration
Syc-Mazurek, S. B., Fernandes, K. A., & Libby, R. T. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.338 · Cited by 53
Contribution of mitogen-activated protein kinases to NMDA-induced neurotoxicity in the rat retina
Munemasa, Y., Ohtani-kaneko, R., Kitaoka, Y., Kuribayashi, K., Isenoumi, K., Kogo, J., Yamashita, K., Kumai, T., Kobayashi, S., Hirata, K., et al. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.014 · Cited by 52
Oliveira, C. S., Rigon, A. P., Leal, R. B., & Rossi, F. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2007.12.007 · Cited by 56
“One of the best known roles ofMAPKs is the control of cell survival, which has been reported in various brain areas including the retina following a series of different insults (Kikuchi et al., 2000; Manabe and Lipton, 2003; Roth et al., 2003; Munemasa et al., 2005).”
BackgroundLipman, T., Tabakman, R., & Lazarovici, P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.022 · Cited by 51
“, 2004) and retinal injury in rats (Roth et al., 2003).”
BackgroundZhao, L., Ling, L., Lu, J., Jiang, F., Sun, J., Zhang, Z., Huang, Y., Liu, X., Zhu, Y., Fu, X., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10460 · Cited by 53
Halder, S. K., Matsunaga, H., Ishii, K. J., Akira, S., Miyake, K., & Ueda, H. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12262 · Cited by 53
“…in the central nervous system including retina and brain following injury/ischemia and disease conditions (Koistinaho and Koistinaho 2002; Jin et al. 2003; Ibrahim et al. 2011), though ischemia-induced expression of pp38 MAPK in other retinal cell types has also been reported (Roth et al. 2003).”
BackgroundPhosphoregulation of Signal Transduction Pathways in Ischemia and Reperfusion
López-Neblina, F., & Toledo-Pereyra, L. H. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.01.007 · Cited by 48
“This protection has been also demonstrated in retinal ischemia [21] and in brain [22].”
BackgroundZhao, W., Fan, C.-L., Hu, X., Ban, X.-X., Wan, H., He, Y., Zhāng, Q., & Xiong, K. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01373-1 · Cited by 46
“Under typical circumstances, phosphorylated forms of ERK, JNK, and p38 rarely exist in the ganglion cell layer (GCL), and expression of p-ERK, p-JNK, and p-p38 is increased after retinal ischemia (Levkovitch-Verbin et al. 2007; Produit-Zengaffinen et al. 2016; Roth et al. 2003).”
BackgroundNeuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury
Shimouchi, A., Yokota, H., Ono, S., Matsumoto, C., Tamai, T., Takumi, H., Narayanan, S. P., Kimura, S., Kobayashi, H., Caldwell, R. B., et al. (2015) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-015-0415-z · Cited by 44
“MAPKs are redox sensitive, and inhibition of ERKs is reported to limit neurodegeneration in ischemic retinopathy [47].”
BackgroundERK1 plays a critical protective role against N‐methyl‐ D ‐aspartate‐induced retinal injury
Nakazawa, T., Shimura, M., Ryu, M., Nishida, K., Pagès, G., Pouysségur, J., & Endo, S. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21472 · Cited by 52
“, 2006), retinal ischemia (Roth et al., 2003), glaucoma (Tezel et al.”
BackgroundD’Alessandro, A., Cervia, D., Catalani, E., Gevi, F., Zolla, L., & Casini, G. (2014) · Molecular BioSystems · doi:10.1039/c3mb70362b · Cited by 50
Expression of phosphorylated c-Jun N-terminal protein kinase (JNK) in experimental glaucoma in rats
Kwong, J. M. K., & Caprioli, J. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.08.017 · Cited by 45
W nt/β‐catenin‐signaling and the formation of M üller glia‐derived progenitors in the chick retina
Gallina, D., Palazzo, I., Steffenson, L. N., Todd, L. J., & Fischer, A. J. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22370 · Cited by 51
“…neurogenesis (Yang et al., 2006), hematopoiesis (Schraml et al., 2009), and angiogenesis (Matsumoto et al., 2002). p38 MAPKsignaling in retinal glia is typically associated with ocular inflammation, ischemic stress or infection (Takeda et al., 2002; Roth et al., 2003; Shamsuddin and Kumar, 2011).”
BackgroundMathew, B., Poston, J. N., Dreixler, J. C., Torres, L. A., Lopez, J., Zelkha, R., Balyasnikova, I. V., Lesniak, M. S., & Roth, S. (2017) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-017-3690-1 · Cited by 43
“Our previous studies on ischemic preconditioning [13, 15, 34, 35], post-ischemic conditioning [36], injection of BMSC conditioned media [16], or hypoxic preconditioned media [9] reported attenuation of apoptosis as a mechanism of protection from retinal ischemia.”
BackgroundSelf-citationp38 MAPK signaling acts upstream of LIF-dependent neuroprotection during photoreceptor degeneration
Agca, C., Gubler, A., Traber, G., Beck, C., Imsand, C., Ail, D., Caprara, C., & Grimm, C. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.323 · Cited by 40
“Active p38 MAPK signaling has been shown to contribute to RGC death after ischemia or optic nerve axotomy.(32,33) In contrast, recent findings suggest that p38”
BackgroundPotential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
de Lara, M. J. P., Avilés‐Trigueros, M., Guzmán‐Aránguez, A., Valiente‐Soriano, F. J., de la Villa, P., Vidal‐Sanz, M., & Pintor, J. J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.05.006 · Cited by 41
“…stress activated proteins in the mouse retina includes INL and GCL and its expression levels have been found by proteomic analysis increased in retinal neurotoxicity (Munemasa et al., 2005; Bessero et al., 2010), glaucomatous damage (Dapper et al., 2013) and retinal ischemia (Roth et al., 2003).”
Yang, J., Yang, N., Luo, J., Cheng, G., Zhang, X., He, T., & Xing, Y. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108281 · Cited by 38
Chowdhury, U. R., Bahler, C. K., Hann, C. R., Chang, M., Resch, Z. T., Romero, M. F., & Fautsch, M. P. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7523 · Cited by 38
ATP sensitive potassium channel openers: A new class of ocular hypotensive agents
Chowdhury, U. R., Dosa, P. I., & Fautsch, M. P. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.04.020 · Cited by 37
“(Atlasz et al., 2007; Roth et al., 2006; Roth et al., 2003) In this review we summarize the salient features of KATP channels and highlight recent studies suggesting that pharmacologic openers of KATP channels such as diazoxide, nicorandil and cromakalim may be a new class of ocular hypotensive agents.”
BackgroundShedding light on myopia by studying complete congenital stationary night blindness
Zeitz, C., Roger, J. E., Audo, I. S., Michiels, C., Sánchez-Farías, N., Varin, J., Frederiksen, H. N., Wilmet, B., Callebert, J., Gimenez, M.-L., et al. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101155 · Cited by 37
Bessero, A. –., Chiodini, F., Rungger‐Brändle, E., Bonny, C., & Clarke, P. G. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06705.x · Cited by 40
“In this case neuroprotection was obtained with a p38 inhibitor but not with either of two different JNK inhibitors (SP600125 and a peptidic inhibitor almost identical to the L-form of D-JNKI-1) (Roth et al. 2003).”
The role of Akt/protein kinase B subtypes in retinal ischemic preconditioning
Dreixler, J. C., Hemmert, J. W., Shenoy, S. K., Shen, Y., Lee, H. T., Shaikh, A. R., Rosenbaum, D. M., & Roth, S. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.11.013 · Cited by 37
“Data (mean SEM) were analyzed as previously described, with ANOVA and post hoc t-testing using Stata version 6.0 (College Station, TX) (Roth et al., 2003, 2006).”
InfluentialSelf-citationGao, F., Li, F., Miao, Y., Xu, L.-J., Zhao, Y., Li, Q., Zhang, S.-H., Wu, J., Sun, X.-H., & Wang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-01557-y · Cited by 34
Self-citationHuang, Y., Li, Z., van Rooijen, N., Wang, N., Pang, C. P., & Cui, Q. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.07.020 · Cited by 34
Effects of epigallocatechin-3-gallate on rat retinal ganglion cells after optic nerve axotomy
Peng, P., Chiou, L.-F., Chao, H., Lin, S. C., Chen, C., Liu, J., & Ko, M. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.01.007 · Cited by 34
Roth, S., Dreixler, J. C., Mathew, B., Balyasnikova, I., Mann, J. R., Boddapati, V., Xue, L., & Lesniak, M. S. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17381 · Cited by 31
Self-citationMitogen-activated protein kinase p38α and retinal ischemic preconditioning
Dreixler, J. C., Barone, F. C., Shaikh, A. R., Du, E., & Roth, S. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.07.006 · Cited by 29
“Procedures have been described in detail previously (Roth et al. 2003; Roth et al. 2006; Dreixler et al. 2008).”
BackgroundMethodInfluentialSelf-citationMueller, B., Park, Y. H., Ma, H.-Y., Dibas, A., Ellis, D. Z., Clark, A. F., & Yorio, T. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.10.007 · Cited by 30
“007 ERK1/2 pathway is neuroprotective against a retinal ischemia insult (Roth et al., 2003).”
BackgroundInfluentialVarano, G. P., Parisi, V., Adornetto, A., Cavaliere, F., Amantea, D., Nucci, C., Corasaniti, M. T., Morrone, L. A., Bagetta, G., & Russo, R. (2017) · PubMed · Cited by 29
Zhang, S., Li, W., Wang, W., Zhang, S. S.-M., Huang, P. C., & Zhang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055683 · Cited by 31
Huang, Y., Cen, L., Luo, J.-M., Wang, N., Zhang, M.-Z., van Rooijen, N., Pang, C. P., & Cui, Q. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.007 · Cited by 30
Protein kinase C subtypes and retinal ischemic preconditioning
Dreixler, J. C., Shaikh, A. R., Shenoy, S. K., Shen, Y., & Roth, S. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.05.015 · Cited by 27
“We have previously described the involvement of adenosine receptors A1 and A2a (Li et al., 1999), several apoptotic proteins (Zhang et al., 2002), heat shock protein 27 (Li et al., 2003), mitogen-activated protein kinases (Roth et al., 2003), and mKATP channels (Roth et al., 2006).”
BackgroundMethodSelf-citationFei, F., Li, J., Rao, W., Liu, W., Chen, X., Su, N., Wang, Y., & Fei, Z. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0198-2 · Cited by 26
Mitogen-activated protein kinase phosphatase-1 (MKP-1) in retinal ischemic preconditioning
Dreixler, J. C., Bratton, A., Du, E., Shaikh, A. R., Savoie, B., Alexander, M., Marcet, M. M., & Roth, S. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2010.10.011 · Cited by 25
“(Roth et al. 2003) Excessive activation of p38 in the Exp Eye Res.”
BackgroundMethodResultSelf-citationChowdhury, U. R., Holman, B. H., & Fautsch, M. P. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11872 · Cited by 25
Inokuchi, Y., Shimazawa, M., Nakajima, Y., Komuro, I., Matsuda, T., Baba, A., Araie, M., Kita, S., Iwamoto, T., & Hara, H. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21906 · Cited by 25
“Next, we measured phosphorylated p38, phosphorylated JNK, and phosphorylated ERK, which are related to cell death signals (Roth et al., 2003).”
MethodIchikawa, A., Nakahara, T., Kurauchi, Y., Mori, A., Sakamoto, K., & Ishii, K. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23358 · Cited by 26
“…activation has been demonstrated in retinal ganglion cell (RGC) survival (Akiyama et al., 2002; Kilic et al., 2005; Hayashi et al., 2007; Zhou et al., 2007; Nakazawa et al., 2008), although the protective effects of ERK on neuronal cells may vary depending on the type of damage (Roth et al., 2003).”
BackgroundAssessment of intrinsic and extrinsic signaling pathway in excitotoxic retinal ganglion cell death
Fahrenthold, B. K., Fernandes, K. A., & Libby, R. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-22848-y · Cited by 25
Involvement of Erythropoietin in Retinal Ischemic Preconditioning
Dreixler, J. C., Hagevik, S., Hemmert, J. W., Shaikh, A. R., Rosenbaum, D. M., & Roth, S. (2009) · Anesthesiology · doi:10.1097/aln.0b013e31819c4601 · Cited by 24
Self-citationChintala, S. K., Putris, N., & Geno, M. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15539 · Cited by 24
Liao, J., Peng, B., Huang, G., Diao, C., Qin, Y., Hong, Y., Lin, J., Lin, Y., Jiang, L., Tang, N., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115052 · Cited by 23
Hayashi, Y., Kitaoka, Y., Munemasa, Y., Ohtani‐Kaneko, R., Kikusui, T., Uematsu, A., Takeda, H., Hirata, K., Mori, Y., & Ueno, S. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21127 · Cited by 23
“Although many reports suggest a beneficial effect of ERK on cell survival, its role may vary dependent on the type of damage to the cell (Roth et al., 2003).”
Background(2010) · PubMed Central · Cited by 22
Hydrostatic Pressure Does Not Cause Detectable Changes in Survival of Human Retinal Ganglion Cells
Osborne, A., Aldarwesh, A., Rhodes, J. D., Broadway, D. C., Everitt, C., & Sanderson, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115591 · Cited by 25
“Increased p38 and JNK phosphorylation has previously been described in animal models of glaucoma [18–21] and p38 or JNK pathway inhibition has been shown to protect RGCs following axotomy [22, 23] and ischemia [18].”
MethodTakeda, K., Kinoshita, I., Shimizu, Y., Ohba, Y., Itoh, T., Matsuno, Y., Shichinohe, T., & Dosaka‐Akita, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-328 · Cited by 23
“The primary antibodies used for immunohistochemistry and immunofluorescence analyses included a rabbit polyclonal antibody to p-c-Jun (Phospho-c-Jun (Ser63) II; Cell Signaling, Cumming Center Beverly, MA) which recognizes c-Jun phosphorylated at Ser 63 [22,23], a mouse anti-β-Catenin monoclonal antibody (IgG1, Clone 1…”
MethodEDG receptors as a potential therapeutic target in retinal ischemia–reperfusion injury
Savitz, S. I., Dhallu, M. S., Malhotra, S., Mammis, A., Ocava, L., Rosenbaum, P. S., & Rosenbaum, D. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.060 · Cited by 26
Munemasa, Y., Kitaoka, Y., Hayashi, Y., Takeda, H., Fujino, H., Ohtani‐Kaneko, R., Hirata, K., & Ueno, S. (2008) · Visual Neuroscience · doi:10.1017/s095252380808053x · Cited by 21
“The pivotal role of MAPKs has been implicated in various forms of retinal neuronal cell damage ~Kikuchi et al., 2000; Roth et al., 2003!.”
BackgroundHata, N., Oshitari, T., Yokoyama, A., Mitamura, Y., & Yamamoto, S. (2008) · Clinical ophthalmology · doi:10.2147/opth.s3009 · Cited by 21
“Similar to a past report (Roth et al 2003), our data showed that JNK expression was detected in many types of cells that were not Fluoro-Jade B positive in ischemic retinas.”
Han, J., Chang, H., Yang, J., Choi, H., Park, H., Jun, H., Choi, J., Paik, S.-S., Chung, K., Shin, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512068 · Cited by 20
“For example, previous studies have reported that p44/42 is a major pro-apoptotic transcriptional factor for retinal ganglion cells [34] and inhibiting the p44/42 pathway protects against damage resulting from ischemic injury of the brain [35].”
Background(2012) · Europe PMC (PubMed Central) · Cited by 20
Action of citicoline on rat retinal expression of extracellular-signal-regulated kinase (ERK1/2)
Park, C., Kim, Y. S., Cheon, E. W., Noh, H. S., Cho, C. H., Chung, I. Y., Yoo, J. M., Kang, S. S., Choi, W. S., & Cho, G. J. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.128 · Cited by 20
Dreixler, J. C., Shaikh, A. R., Alexander, M. J., Savoie, B. T., & Roth, S. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.06.015 · Cited by 20
“Electroretinography Before and after Retinal Ischemia Procedures we used have been described in detail previously (Roth et al. 2003; Roth et al. 2006, Dreixler, 2008).”
BackgroundMethodSelf-citationProtein Kinases in Organ Ischemia and Reperfusion
Toledo-Pereyra, L. H., López-Neblina, F., & Toledo, A. H. (2008) · Journal of Investigative Surgery · doi:10.1080/08941930802130149 · Cited by 19
“This protection has been also demonstrated in retinal ischemia [74] and in the brain [75].”
BackgroundHuang, Y., Li, Z., Wang, N., van Rooijen, N., & Cui, Q. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-78 · Cited by 21
“The acute IOP elevation procedure has previously been reported [39].”
MethodMammone, T., Chidlow, G., Casson, R. J., & Wood, J. P. M. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.01.002 · Cited by 18
“…in response to N-methyl-D-aspartate (Munemasa et al., 2005; Manabe and Lipton, 2003) or glutamate injections (Zhou et al., 2007), retinal ischemia (Roth et al., 2003; Kim et al., 2016) optic nerve transection (Nakazawa et al., 2002; Nitzan et al., 2006; Kikuchi et al., 2000),…”
BackgroundResultInfluentialHuoxue-Tongluo-Lishui-Decoction is visual-protective against retinal ischemia-reperfusion injury
Han, L., Zhang, M., Yang, Z., Diao, K., Jia, X., Li, M., & Tian, G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109998 · Cited by 18
Betulinic acid derivatives can protect human Müller cells from glutamate-induced oxidative stress
Cheng, Z., Zhang, T., Zheng, J., Ding, W., Wang, Y., Li, Y., Zhu, L., Murray, M. T., & Zhou, F. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111509 · Cited by 20
Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension
Hu, Q., HUANG, C., Wang, Y., & Wu, R. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4287 · Cited by 18
“In the rat retina, Roth et al (38) revealed that the expression of P-ERK peaked between 1 and 6 h following ischemia, followed by a decrease.”
InfluentialDimitriu, C., Bach, M., Lagrèze, W. A., & Jehle, T. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1869 · Cited by 17
Martínez‐Gil, N., Vidal‐Gil, L., Flores‐Bellver, M., Maisto, R., Sancho-Pellúz, J., Díaz-Llopis, M., Barcia, J. M., & Romero, F. J. (2020) · Antioxidants · doi:10.3390/antiox9090776 · Cited by 16
Liedtke, T., Naskar, R., Eisenacher, M., & Thanos, S. (2006) · Glia · doi:10.1002/glia.20447 · Cited by 15
Liu, J., Huang, Q., Higdon, J., Liu, W., Xie, T., Yamashita, T., Cheon, K., Cheng, C., & Zuo, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi325 · Cited by 15
“There is a report of little phospho-JNKs staining in normal retina in rats (17).”
BackgroundKodati, B., Stankowska, D. L., Krishnamoorthy, V. R., & Krishnamoorthy, R. R. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.6.13 · Cited by 14
Vander, S., & Levkovitch-Verbin, H. (2012) · Current Eye Research · doi:10.3109/02713683.2012.673679 · Cited by 14
Produit-Zengaffinen, N., Favez, T., Pournaras, C. J., & Schorderet, D. F. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_90 · Cited by 13
Dreixler, J. C., Sampat, A., Shaikh, A. R., Alexander, M. J., Marcet, M. M., & Roth, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9523-5 · Cited by 12
“Akt Subtype Cellular Localization in the Retina In a previous study, we defined the cellular localization of p38 in the retina (Roth et al. 2003).”
BackgroundMethodResultSelf-citationBian, Y., Ren, L., Wang, L., Xu, S.-M., Tao, J., Zhang, X., Huang, Y., Qian, Y., Zhang, X., Song, Z., et al. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.04.010 · Cited by 11
Kumar, V., Shariati, A., Mesentier-Louro, L. A., Oh, A. J., Russano, K. R., Goldberg, J. L., & Liao, Y. J. (2020) · Current Eye Research · doi:10.1080/02713683.2020.1826976 · Cited by 12
Huang, S., Huang, P., Yu, H., Lin, Z., Liu, X., Shen, X. P., Guo, L., & Zhong, Y. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27507 · Cited by 11
Ding, X.-Y., Gu, R.-P., Tang, W.-Y., Shu, Q.-M., Xu, G.-Z., & Zhang, M. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.246064 · Cited by 10
Mechanisms of retinal ganglion cell injury following acute increases in intraocular pressure
Garner, M. A., Strickland, R. G., Girkin, C. A., & Gross, A. K. (2022) · Frontiers in Ophthalmology · doi:10.3389/fopht.2022.1007103 · Cited by 8
Alhumaid, A., Liu, F., Shan, S., Jafari, E. A., Nourin, N., Somanath, P. R., & Narayanan, S. P. (2024) · Tissue Barriers · doi:10.1080/21688370.2024.2347070 · Cited by 7
“54 Our data suggests that inhibiting SMOX reduces vascular damage in the OIR retina by regulating ERK and p38 signaling pathways.”
Changes in BDNF and MAPK Signaling Pathways in Experimental Glaucoma
Fabiani, C., & Cerri, E. (2016) · Journal of Clinical & Experimental Ophthalmology · doi:10.4172/2155-9570.1000530 · Cited by 7
“In particular, we performed western blot analysis to study retinal levels of the BDNF and its receptor, TrkB, and to better understand possible modulation of p38 MAPK and ERK1/2 activation at different stages of retinal degeneration in DBA/2J mice.”
BackgroundInfluential
Metadata
- Authors
- Roth, S., Shaikh, A. R., Hennelly, M. M., Li, Q., Bindokas, V., & Graham, C. E.
- Affiliations
- University of Chicago (US)
- From the Departments of Anesthesia and Critical Care,
- Neurobiology, and
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2003-12-01
- Volume
- 44
- Issue
- 12
- Pages
- 5383
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2130729942
- Cited by
- 117
- References
- 56
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 9 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 10 · 2014: 7 · 2013: 5 · 2012: 4
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- Funders
- National Eye Institute (EY10343)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- mitogen-activated protein kinase, retinal ischemia, p38 MAPK, ERK, JNK, MAPK phosphorylation, MAPK inhibition, neuroprotection, apoptosis, Müller cells, retinal ganglion cells, amacrine cells, bipolar cells, intraocular pressure elevation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.